Nearly 50% of the VKH patients studied here carry HLA-B22, which implicates a B22-mediated immunological nonresponsiveness to viral infections, which may play a role in the pathogenesis of VKH disease. This evidence concerns the gene NDUFB9 and viral infectious disease.